BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 33164812)

  • 1. Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer.
    Dilly AK; Honick BD; Frederick R; Elapavaluru A; Velankar S; Makala H; Hitchens TK; Foley LM; Guo J; Beumer JH; Rigatti LH; Lee YJ; Bartlett DL; Choudry HA
    Transl Res; 2021 Mar; 229():100-114. PubMed ID: 33164812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A formulation for in situ lysis of mucin secreted in pseudomyxoma peritonei.
    Pillai K; Akhter J; Chua TC; Morris DL
    Int J Cancer; 2014 Jan; 134(2):478-86. PubMed ID: 23843173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin/fluorouracil/leucovorin (FOLFOX4).
    Chen CF; Huang CJ; Kang WY; Hsieh JS
    World J Surg Oncol; 2008 Nov; 6():118. PubMed ID: 19014441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study.
    Valle SJ; Akhter J; Mekkawy AH; Lodh S; Pillai K; Badar S; Glenn D; Power M; Liauw W; Morris DL
    Eur J Surg Oncol; 2021 Jan; 47(1):115-122. PubMed ID: 31679953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic anti-inflammatory drug therapy inhibits gel-forming mucin production in a murine xenograft model of human pseudomyxoma peritonei.
    Choudry HA; Mavanur A; O'Malley ME; Zeh HJ; Guo Z; Bartlett DL
    Ann Surg Oncol; 2012 May; 19(5):1402-9. PubMed ID: 22302271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of an inguinal hernia in patients with pseudomyxoma peritonei.
    Sugarbaker PH
    Eur J Surg Oncol; 2017 Jun; 43(6):1083-1087. PubMed ID: 28131668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma.
    Mavanur AA; Parimi V; O'Malley M; Nikiforova M; Bartlett DL; Davison JM
    Int J Exp Pathol; 2010 Aug; 91(4):357-67. PubMed ID: 20586814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin.
    Sugarbaker PH; Bijelic L; Chang D; Yoo D
    J Surg Oncol; 2010 Nov; 102(6):576-81. PubMed ID: 20737420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors.
    Dilly A; Honick BD; Lee YJ; Bartlett DL; Choudry HA
    Cancer Med; 2020 Mar; 9(5):1753-1767. PubMed ID: 31958897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis.
    Wagner PL; Jones D; Aronova A; Shia J; Weiser MR; Temple LK; Chung KY; O'Reilly EM; Kelsen D; Paty PB; Nash GM
    Dis Colon Rectum; 2012 Apr; 55(4):407-15. PubMed ID: 22426264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial Neoplasms.
    Choe JH; Overman MJ; Fournier KF; Royal RE; Ohinata A; Rafeeq S; Beaty K; Phillips JK; Wolff RA; Mansfield PF; Eng C
    Ann Surg Oncol; 2015 Aug; 22(8):2578-84. PubMed ID: 25582740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcification of pseudomyxoma peritonei following intraperitoneal chemotherapy: CT demonstration.
    Miller DL; Udelsman R; Sugarbaker PH
    J Comput Assist Tomogr; 1985; 9(6):1123-4. PubMed ID: 2997312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei.
    Legué LM; Creemers GJ; de Hingh IHJT; Lemmens VEPP; Huysentruyt CJ
    Clin Colorectal Cancer; 2019 Mar; 18(1):1-7. PubMed ID: 30611664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix.
    Lopez-Ramirez F; Gushchin V; Sittig M; King MC; Baron E; Nikiforchin A; Nieroda C; Sardi A
    Ann Surg Oncol; 2022 Jun; 29(6):3390-3401. PubMed ID: 35133518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
    Ronnett BM; Zahn CM; Kurman RJ; Kass ME; Sugarbaker PH; Shmookler BM
    Am J Surg Pathol; 1995 Dec; 19(12):1390-408. PubMed ID: 7503361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms.
    Yan TD; Bijelic L; Sugarbaker PH
    Ann Surg Oncol; 2007 Aug; 14(8):2289-99. PubMed ID: 17541772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
    Asare EA; Compton CC; Hanna NN; Kosinski LA; Washington MK; Kakar S; Weiser MR; Overman MJ
    Cancer; 2016 Jan; 122(2):213-21. PubMed ID: 26506400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucinous Adenocarcinoma of the Appendix With Histologic Response to Neoadjuvant Chemotherapy: Review of Histologic and Clinical Spectrum of Epithelial Neoplastic Mucinous Lesions of the Appendix.
    Copur M; Cushman-Vokoun A; Padussis J; Whitney W; Schroeder C; Herold D; Lintel N; Horn A
    Oncology (Williston Park); 2021 Jun; 35(6):335-340. PubMed ID: 34161053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of bromelain and acetylcysteine in pseudomyxoma peritonei (PMP) caused by low-grade appendiceal mucinous neoplasm (LAMN): a case report.
    Geisel D; Langen U; Rüdiger T
    J Med Case Rep; 2023 Jun; 17(1):297. PubMed ID: 37381056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
    Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
    Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.